ESA trains next generation of atmospheric ... ( In a world in which human activity i...)

ESA trains next generation of atmospheric scientists

Date:9/22/2008

In a world in which human activity is beginning to alter atmospheric composition with substantial implications for climate and air quality, it is more pressing than ever that the scientists of tomorrow understand atmospheric processes and how the processes may change in order to anticipate the effects and minimise potential dangers.

ESA's Advanced Atmospheric Training Course, held 15?? September at University of Oxford, UK, brought 50 students from 23 different countries together with world-renowned atmospheric scientists so they could educate and train them to use state-of-the-art space-based atmospheric sensors.

"It is absolutely vital that the next generation of research scientists who are going to be looking at these problems and carrying forward the programme for ESA and other agencies have a full and deep knowledge of the satellite observations they are going to be using," Dr Brian Kerridge of the UK's Rutherford Appleton Laboratory explained. "The ESA course is able to provide the in-depth level of training necessary to fulfil those functions."

During the course, six European experts discussed various topics ranging from the current use of satellite instruments for remote sensing of trace gases in the stratosphere and troposphere, clouds, aerosols and UV information and pollution monitoring to data handling, retrieval and radiative transfer, validation, data assimilation and modelling.

The students, selected from over 100 applicants, had hands-on training and direct access to the lecturers and were encouraged to ask questions and discuss their projects during the course, which was hosted by Oxford's Physics department.

"The lecturers were excellent and are literally some of the forefathers of their particular fields, so it has really helped me to be able to discuss things with them," said Sam Illingworth, a PhD student from the University of Leicester. "I spoke with Dr Clive Rodgers and Dr Bruno Carli about a
'/>"/>

Contact: Mariangela D'Acunto
mariangela.dacunto@esa.int
39-069-418-0856
European Space Agency
Source:Eurekalert

0

GOOD

Page: 1 2 3
Related biology news :

1. Scripps scientists develop new tests that identify lethal prion strains quickly and accurately
2. Entrust Expands Relationship with Slovenia, Implements Second-generation ePassport Solution
3. Rhode Island Hospital study finds link between obesity, type 2 diabetes and neurodegeneration
4. Songbirds may hold key to advances in treatment of brain degeneration
5. Broad Institute researchers introduce next generation tool for visualizing genomic data
6. The epigenetics of increasing weight through the generations
7. Study shows single insecticide application can kill 3 cockroach generations
8. bioMETRX, Inc. Partners with Biometric Solutions, LLC to Deliver Next Generation Finger Activated Technology
9. Platinum Solutions, Inc. Teams with Lockheed Martin on Federal Bureau of Investigations Next Generation Identification Program
10. Pitt faculty receive awards to explore next-generation technologies
11. Pyramid Launches TimeTrax Bio Generation II

Post Your Comments:

(Date:5/21/2013)... the nation,s land and water resources could likely support ... 25 billion gallons of algae-based fuel a year in ... , The findings come from an in-depth look at ... significant amounts of algae in large, specially built shallow ... issue of Environmental Science and Technology , published ...

(Date:5/21/2013)... a class of pharmaceuticals can both prevent and treat ... as "TSPO ligands," are currently used for certain types ... TSPO ligand in young adult mice when pathology was ... pathology was quite severe," said lead researcher Christian Pike ... reduced measures of pathology and improved behavior at both ...

(Date:5/21/2013)... all types become most deadly when they metastasize and ... this stage, it becomes very difficult for doctors to ... Now, researchers at the University of Missouri have found ... tumor cells wherever they may be in the body. ... MU College of Veterinary Medicine, says being able to ...

Breaking Biology News(10 mins):Going green: Nation equipped to grow serious amounts of pond scum for fuel 2 Going green: Nation equipped to grow serious amounts of pond scum for fuel 3 Going green: Nation equipped to grow serious amounts of pond scum for fuel 4 Drugs found to both prevent and treat Alzheimer's disease in mice 2 MU researchers develop radioactive nanoparticles that target cancer cells 2

[0] Going green: Nation equipped to grow serious amounts of pond scum for fuel [0] Drugs found to both prevent and treat Alzheimer's disease in mice [0] MU researchers develop radioactive nanoparticles that target cancer cells

... MIT scientists have found a new way that DNA can ... discovering that a mold used to cast a metal tool ... shapes each showing distinct functional roles. Professor Manolis Kellis ... 1 issue of the journal Genes & Development that in ...

... Advanced Public Safety Minimizes ... Cost and Increases Accuracy -, WALL, N.J., ... International, Inc. (OTC Bulletin Board: BKYI), a leader ... Advanced Public Safety (APS), a leading provider of ...

... Cold Spring Harbor Laboratorys (CSHL) researcher Raffaella Sordella, Ph.D. ... Foundation to Conquer Lung Cancer. The two-year grant will ... class of genetic mutations that appear to be a ... of cancer deaths in the United States. The ...

Cached Biology News:MIT reports new twist in microRNA biology 2 Missouri Police Department Introduces Electronic Traffic Citations 2 Missouri Police Department Introduces Electronic Traffic Citations 3 Missouri Police Department Introduces Electronic Traffic Citations 4 Cold Spring Harbor Laboratory's lung cancer research program awarded $100,000 grant 2

MIT reports new twist in microRNA biology Missouri Police Department Introduces Electronic Traffic Citations Cold Spring Harbor Laboratory's lung cancer research program awarded $100,000 grant

(Date:5/21/2013)... OXFORD, England , May 22, 2013 ... inhaled, novel drug-only formulation of glycopyrronium bromide designed using ... speciality pharmaceutical company developing a portfolio of inhaled ... 2 clinical study with PSX1002 that will assess its ... range of doses in patients with moderate to severe ...

(Date:5/21/2013)... study led by George Washington University Professor Tianshu ... ice in small droplets is strongly size-dependent, an ... nanoscale. The formation of ice at the nanoscale ... answer also has important implications for climate research ... ice from supercooled water is generally initiated by ...

(Date:5/21/2013)... Smarter Security, Inc., provider of premium, ... that Genzyme, a Sanofi company and leading biotech company, ... for a multi-use facility in the United States. With ... buildings, this latest order underscores the satisfaction and success ... device improving doorway access control. , “We ...

(Date:5/21/2013)... Md. , May 21, 2013 MacroGenics, ... 1 study of margetuximab (MGAH22), an Fc-modified chimeric ... tumors expressing the HER2 oncoprotein," will be presented ... Society of Clinical Oncology during the Developmental Therapeutics ... 3 at 4:15 – 4:30 PM. The presentation ...

Breaking Biology Technology:Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2 Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3 Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4 Study led by GW professor provides better understanding of water's freezing behavior at nanoscale 2 Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 2 Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 3 MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2 MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3

[0] Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)[0] Study led by GW professor provides better understanding of water's freezing behavior at nanoscale [0] Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security [0] MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer

... ... ... ... ...

Nutrastar International, Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing Sigma-Aldrich(R) Focuses on Biology With Launch of New Life Science Brand Platform China-Biotics, Inc. Appointed Grayling as Strategic Investor Relations Advisor

UBN-1 (C-20)...

Mouse HAI-1 Ectodomain MAb (Clone 199732)...

Human IL-29/IFN-lambda 1 Biotinylated Affinity Purified PAb...

Anti-Potassium Channel EAG-1 Immunogen: Synthetic peptide from the C-terminus of rat Kv10.1 (Accession Q63472). The immunogen sequence is identical in mouse and 14/16 residues identical in human...

Biology Products:

Goat Anti-Human UBN-1 (C-20) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.Rat Anti-Mouse HAI-1 Ectodomain Monoclonal Antibody, Unconjugated, Clone 199732 from R&D Systems Goat Anti-Human IL-29 / IFN-lambda 1 Polyclonal Antibody, Biotin Conjugated from R&D Systems Rabbit Anti-Rat Potassium Channel EAG-1 Antibody, Unconjugated from CHEMICON